David Gionco, Chief Accounting Officer at STEMLINE THERAPEUTICS INC (STML), sold 16,841 shares at $17.20 ($291K) on 2018-03-12, disclosed to the SEC on 2018-03-14.
Seasonal sale ($291k) by Chief Accounting Officer — this insider has traded STML in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.20 | 7,658 | $132K | 45.2% |
| 2 | $17.20 | 7,658 | $132K | 45.2% |
| 3 | $18.28 | 1,525 | $28K | 9.6% |
| Total | $17.30 avg | 16,841 | $291K | 100% |
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |